(Q46068063)

19 December 2017

title

Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates (English)

1 reference

19 December 2017

0 references

1 reference

1

1 reference

19 December 2017

Tjeerd P van Staa

4

1 reference

19 December 2017

Cyrus Cooper

object named as

C Cooper

5

0 references

author name string

A L Cooper

2

1 reference

19 December 2017

S M Cockle

3

1 reference

19 December 2017

language of work or name

English

0 references

publication date

31 March 2009

1 reference

19 December 2017

Osteoporosis International

published in

1 reference

19 December 2017

volume

20

1 reference

19 December 2017

issue

12

1 reference

19 December 2017

page(s)

1989-1998

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-009-0891-4

exact match

0 references

cites work

Consequences of hip fracture on activities of daily life and residential needs.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-009-0891-4

Use of proton pump inhibitors and risk of osteoporosis-related fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-009-0891-4

Risk factors for hip fracture in men. Hip Fracture Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-009-0891-4

Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-009-0891-4

Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis

21 January 2018

1 reference

12 December 2020

Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study

1 reference

12 December 2020

Use of oral corticosteroids and risk of fractures.

1 reference

12 December 2020

Functional ability after hip fracture among patients home-dwelling at the time of fracture

1 reference

12 December 2020

Risk-adjusted mortality rates of elderly veterans with hip fractures.

1 reference

12 December 2020

Pharmacovigilance study of alendronate in England

1 reference

12 December 2020

Bisphosphonate use and subsequent prescription of acid suppressants

1 reference

12 December 2020

Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases

1 reference

12 December 2020

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture

1 reference

12 December 2020

Determinants of adherence to osteoporosis treatment in clinical practice

1 reference

12 December 2020

Utility of medical and drug history in fracture risk prediction among men and women

1 reference

12 December 2020

Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England

1 reference

12 December 2020

Modularity of osteoclast behaviour and "mode-specific" inhibition of osteoclast function

1 reference

12 December 2020

Epidemiology of fractures in England and Wales

1 reference

12 December 2020

Epidemiology of Osteoporosis

1 reference

12 December 2020

Factors influencing compliance in long-term proton pump inhibitor therapy in general practice

1 reference

12 December 2020

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

1 reference

12 December 2020

Fracture risk with intermittent high-dose oral glucocorticoid therapy

1 reference

12 December 2020

Long-term proton pump inhibitor therapy and risk of hip fracture

1 reference

12 December 2020

Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial

1 reference

12 December 2020

10.1007/S00198-009-0891-4

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017